Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

clear all | select all

Conference Years:

clear all | select all

Days Within Meeting:

clear all | select all

Conferences:

Availability:

clear all | select all

Participation Type:

clear all | select all

Topic Tracks*:

clear all | select all

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 12 records per page: next > | last >>
pages: 1 2 3 4 5 ... 9 10 11 12 presentations: 1 to 25 of 280
Manipulating the Immune System in Cancer Therapy
Introduction
Padmanee Sharma
UT MD Anderson Cancer Ctr., Houston, TX, United States
from AACR Annual Meeting 2019 on April 2, 2019 8:15 AM-10:15 AM
Manipulating the Immune System in Cancer Therapy
T-cell therapy targeting unique cancer mutations
Steven A Rosenberg
National Cancer Inst., Bethesda, MD, United States
from AACR Annual Meeting 2019 on April 2, 2019 8:15 AM-10:15 AM
Manipulating the Immune System in Cancer Therapy
  •  
  • Free
  • Unknown permission
    for presentation
  •  
  •  
Redirecting T cells for cancer immunotherapy using next-generation bispecific antibodies and fusion proteins
Pablo Umana
Roche Innovation Center Zurich, Zurich, Switzerland
from AACR Annual Meeting 2019 on April 2, 2019 8:15 AM-10:15 AM
Manipulating the Immune System in Cancer Therapy
Taming the beast: Strategies to target the immune-suppressive macrophage to enhance cancer immune therapy
Judith A Varner
UCSD Moores Cancer Ctr., La Jolla, CA, United States
from AACR Annual Meeting 2019 on April 2, 2019 8:15 AM-10:15 AM
Manipulating the Immune System in Cancer Therapy
Mismatch repair deficiency: A connection between the immune system and cancer genetics
Dung T Le
Johns Hopkins Sidney Kimmel Comp. Cancer Ctr., Baltimore, MD, United States
from AACR Annual Meeting 2019 on April 2, 2019 8:15 AM-10:15 AM
Manipulating the Immune System in Cancer Therapy
Wrap-up and opportunities for the future
Padmanee Sharma
UT MD Anderson Cancer Ctr., Houston, TX, United States
from AACR Annual Meeting 2019 on April 2, 2019 8:15 AM-10:15 AM
Novel Rational Checkpoint Inhibitors
Introduction
Silvia C Formenti
Weill Cornell Medical College, New York, NY, United States
from AACR Annual Meeting 2019 on April 2, 2019 10:30 AM-12:45 PM
Novel Rational Checkpoint Inhibitors
Neoadjuvant immuno-radiotherapy (NIRT) in head and neck cancer: Phase I/Ib study of combined PD-1/SBRT prior to surgical resection
Rom Leidner
EACRI - Providence Cancer Center, Portland, OR, United States
from AACR Annual Meeting 2019 on April 2, 2019 10:30 AM-12:45 PM
Novel Rational Checkpoint Inhibitors
Discussant
Christine H Chung
Moffitt Cancer Center, Tampa, FL, United States
from AACR Annual Meeting 2019 on April 2, 2019 10:30 AM-12:45 PM
Novel Rational Checkpoint Inhibitors
Phase (Ph) I/II study of MBG453± spartalizumab (PDR001) in patients (pts) with advanced malignancies
Giuseppe Curigliano
Istituto Europeo di Oncologia IRCCS, Milan, Italy
from AACR Annual Meeting 2019 on April 2, 2019 10:30 AM-12:45 PM
Novel Rational Checkpoint Inhibitors
Discussant
David S Hong
UT MD Anderson Cancer Ctr., Houston, TX, United States
from AACR Annual Meeting 2019 on April 2, 2019 10:30 AM-12:45 PM
Novel Rational Checkpoint Inhibitors
Gilteritinib significantly prolongs overall survival in patients with FLT3-mutated (FLT3mut+) relapsed/refractory (R/R) acute myeloid leukemia (AML): Results from the Phase III ADMIRAL trial
Alexander E Perl
Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, United States
from AACR Annual Meeting 2019 on April 2, 2019 10:30 AM-12:45 PM
Novel Rational Checkpoint Inhibitors
Discussant
Tapan M. Kadia
UT MD Anderson Cancer Ctr., Houston, TX, United States
from AACR Annual Meeting 2019 on April 2, 2019 10:30 AM-12:45 PM
Novel Rational Checkpoint Inhibitors
Phase I dose-escalation study of endoscopic intratumoral injection of OBP-301 (telomelysin) with radiotherapy in esophageal cancer patients unfit for standard treatments
Toshiyoshi Fujiwara
Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
from AACR Annual Meeting 2019 on April 2, 2019 10:30 AM-12:45 PM
Novel Rational Checkpoint Inhibitors
Discussant
Geoffrey Y Ku
Memorial Sloan Kettering Cancer Center, New York, NY, United States
from AACR Annual Meeting 2019 on April 2, 2019 10:30 AM-12:45 PM
A Journey from Phosphotyrosine to Phosphohistidine with Unexpected Links to Pancreatic Cancer and Liver Cancer along the Way
A journey from phosphotyrosine to phosphohistidine with unexpected links to pancreatic cancer and liver cancer along the way
Tony Hunter
Salk Institute, La Jolla, CA, United States
from AACR Annual Meeting 2019 on April 2, 2019 7:00 AM-8:00 AM
A-to-I RNA Editing in Cancer
A-to-I RNA editing in cancer
Erez Y Levanon
Bar-Ilan University, Ramat-Gan, Israel
from AACR Annual Meeting 2019 on April 2, 2019 7:00 AM-8:00 AM
Defining and Targeting Malignant Brain Tumor Hierarchies
Defining and targeting malignant brain tumor hierarchies
Peter B Dirks
The Hospital for Sick Children, Toronto, ON, Canada
from AACR Annual Meeting 2019 on April 2, 2019 7:00 AM-8:00 AM
Distinguished Lecture: Overcoming Resistance to Antibody-Targeted Cancer Immunotherapy
Overcoming resistance to antibody-targeted cancer immunotherapy
Louis M Weiner
Georgetown Lombardi Comp. Cancer Ctr., Washington, DC, United States
from AACR Annual Meeting 2019 on April 2, 2019 7:00 AM-8:00 AM
Engaging and Involving Patients in Translational Cancer Research
Engaging and involving patients in translational cancer research
Bodour Salhia
University of Southern California, Los Angeles, CA, United States
from AACR Annual Meeting 2019 on April 2, 2019 7:00 AM-8:00 AM
New Single-Cell Methods for Oncology and Immuno-oncology
  •  
  • Free
  • Unknown permission
    for presentation
  •  
  •  
New single-cell methods for oncology and immuno-oncology
James R Heath
California Inst. of Technology, Pasadena, CA, United States
from AACR Annual Meeting 2019 on April 2, 2019 7:00 AM-8:00 AM
Next-Generation Characterization and Functional Mapping of the Cancer Cell Line Encyclopedia: Implications for Targeting Dysregulated Metabolism in Cancer
Next-generation characterization and functional mapping of the cancer cell line encyclopedia: Implications for targeting dysregulated metabolism in cancer
William R. Sellers
Broad Institute, Cambridge, MA, United States
from AACR Annual Meeting 2019 on April 2, 2019 7:00 AM-8:00 AM
Novel Therapeutic Strategies in Multiple Myeloma
Novel therapeutic strategies in multiple myeloma
Kenneth C Anderson
Dana-Farber Cancer Inst., Boston, MA, United States
from AACR Annual Meeting 2019 on April 2, 2019 7:00 AM-8:00 AM
Obesity: Changing the Landscape for Cancer Risk in Populations
Obesity: Changing the landscape for cancer risk in populations
Elizabeth A Platz
Johns Hopkins School of Public Health, Baltimore, MD, United States
from AACR Annual Meeting 2019 on April 2, 2019 7:00 AM-8:00 AM
Prostate Cancer Health Disparity
Prostate cancer health disparity
Timothy R Rebbeck
Harvard School of Public Health, Boston, MA, United States
from AACR Annual Meeting 2019 on April 2, 2019 7:00 AM-8:00 AM
<< first | < prev page: of 12 records per page: next > | last >>
pages: 1 2 3 4 5 ... 9 10 11 12 presentations: 1 to 25 of 280